Latest Insider Transactions at Teladoc Health, Inc. (TDOC)
This section provides a real-time view of insider transactions for Teladoc Health, Inc. (TDOC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Teladoc Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Teladoc Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 14
2021
|
Yulun Wang Head of Research & Development |
SELL
Open market or private sale
|
Indirect |
8,000
-3.18%
|
$1,808,000
$226.66 P/Share
|
|
Jan 14
2021
|
Glen Tullman Director |
SELL
Open market or private sale
|
Direct |
164,931
-37.42%
|
$37,109,475
$225.12 P/Share
|
|
Jan 14
2021
|
Glen Tullman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
164,931
+27.23%
|
$824,655
$5.26 P/Share
|
|
Jan 11
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-26.29%
|
$681,000
$227.33 P/Share
|
|
Jan 11
2021
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+20.81%
|
$66,000
$22.3 P/Share
|
|
Jan 06
2021
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-18.43%
|
$612,000
$204.0 P/Share
|
|
Jan 06
2021
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+15.56%
|
$66,000
$22.3 P/Share
|
|
Jan 05
2021
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-5.11%
|
$6,000,000
$200.15 P/Share
|
|
Jan 04
2021
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,529
-92.67%
|
$503,271
$199.8 P/Share
|
|
Jan 04
2021
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
2,529
+37.58%
|
$75,870
$30.42 P/Share
|
|
Jan 04
2021
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-23.15%
|
$796,000
$199.8 P/Share
|
|
Jan 04
2021
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+18.8%
|
$88,000
$22.3 P/Share
|
|
Dec 15
2020
|
Yulun Wang Head of Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
$72,000
$16.92 P/Share
|
|
Dec 14
2020
|
Yulun Wang Head of Research & Development |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$497,500
$199.24 P/Share
|
|
Dec 14
2020
|
Yulun Wang Head of Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.92 P/Share
|
|
Dec 10
2020
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-26.29%
|
$576,000
$192.17 P/Share
|
|
Dec 10
2020
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+20.81%
|
$66,000
$22.3 P/Share
|
|
Dec 08
2020
|
Hemant Taneja Director |
SELL
Open market or private sale
|
Indirect |
4,900
-100.0%
|
$965,300
$197.39 P/Share
|
|
Dec 04
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-13.09%
|
$408,000
$204.0 P/Share
|
|
Dec 04
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+11.58%
|
$44,000
$22.3 P/Share
|
|
Dec 04
2020
|
Yulun Wang Head of Research & Development |
SELL
Open market or private sale
|
Direct |
6,069
-100.0%
|
$1,213,800
$200.0 P/Share
|
|
Dec 04
2020
|
Yulun Wang Head of Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,069
+50.0%
|
$97,104
$16.92 P/Share
|
|
Dec 03
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-0.82%
|
$1,000,000
$200.52 P/Share
|
|
Dec 03
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,389
-25.7%
|
$277,800
$200.0 P/Share
|
|
Dec 03
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,389
+20.45%
|
$30,558
$22.3 P/Share
|
|
Dec 03
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,611
-92.89%
|
$511,756
$196.5 P/Share
|
|
Dec 03
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
2,611
+38.03%
|
$78,330
$30.4 P/Share
|
|
Dec 01
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-23.15%
|
$792,000
$198.66 P/Share
|
|
Dec 01
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+18.8%
|
$88,000
$22.3 P/Share
|
|
Dec 01
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-3.92%
|
$4,850,000
$194.27 P/Share
|
|
Nov 27
2020
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
3,924
-3.75%
|
$761,256
$194.89 P/Share
|
|
Nov 25
2020
|
Sandra L Fenwick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,173
+16.8%
|
-
|
|
Nov 25
2020
|
Karen L Daniel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,173
+25.37%
|
-
|
|
Nov 25
2020
|
Christopher Bischoff |
BUY
Exercise of conversion of derivative security
|
Direct |
713
+16.18%
|
-
|
|
Nov 10
2020
|
Daniel Trencher CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-26.29%
|
$540,000
$180.17 P/Share
|
|
Nov 10
2020
|
Daniel Trencher CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+20.81%
|
$66,000
$22.3 P/Share
|
|
Nov 04
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,389
-25.7%
|
$277,800
$200.0 P/Share
|
|
Nov 04
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,389
+20.45%
|
$30,558
$22.3 P/Share
|
|
Nov 04
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-13.09%
|
$408,000
$204.0 P/Share
|
|
Nov 04
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+11.58%
|
$44,000
$22.3 P/Share
|
|
Nov 04
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-0.78%
|
$1,000,000
$200.27 P/Share
|
|
Nov 03
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-3.74%
|
$4,825,000
$193.76 P/Share
|
|
Nov 03
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
310
+0.05%
|
$1,860
$6.01 P/Share
|
|
Nov 03
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,612
-92.89%
|
$501,504
$192.0 P/Share
|
|
Nov 03
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
2,612
+38.03%
|
$78,360
$30.42 P/Share
|
|
Nov 03
2020
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
78,707
+42.9%
|
-
|
|
Nov 02
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-23.15%
|
$776,000
$194.0 P/Share
|
|
Nov 02
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+18.8%
|
$88,000
$22.3 P/Share
|
|
Oct 30
2020
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,911
+50.0%
|
-
|
|
Oct 06
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-4.3%
|
$6,660,000
$222.26 P/Share
|